BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Villarán RF, Espinosa-Oliva AM, Sarmiento M, De Pablos RM, Argüelles S, Delgado-Cortés MJ, Sobrino V, Van Rooijen N, Venero JL, Herrera AJ. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem. 2010;114:1687-1700. [PMID: 20584104 DOI: 10.1111/j.1471-4159.2010.06879.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Kavanagh E, Burguillos MA, Carrillo-Jimenez A, Oliva-Martin MJ, Santiago M, Rodhe J, Joseph B, Venero JL. Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model. Aging (Albany NY) 2015;7:673-89. [PMID: 26405176 DOI: 10.18632/aging.100805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
2 Pflieger FJ, Hernandez J, Schweighöfer H, Herden C, Rosengarten B, Rummel C. The role of neutrophil granulocytes in immune-to-brain communication. Temperature (Austin) 2018;5:296-307. [PMID: 30574524 DOI: 10.1080/23328940.2018.1538598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B. Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark. Eur J Neurol 2012;19:864-9. [PMID: 22248366 DOI: 10.1111/j.1468-1331.2011.03643.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
4 Spielman LJ, Gibson DL, Klegeris A. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochem Int 2018;120:149-63. [PMID: 30114473 DOI: 10.1016/j.neuint.2018.08.005] [Cited by in Crossref: 88] [Cited by in F6Publishing: 69] [Article Influence: 29.3] [Reference Citation Analysis]
5 Herrick MK, Tansey MG. Is LRRK2 the missing link between inflammatory bowel disease and Parkinson's disease? NPJ Parkinsons Dis 2021;7:26. [PMID: 33750819 DOI: 10.1038/s41531-021-00170-1] [Reference Citation Analysis]
6 Nikodemova M, Small AL, Kimyon RS, Watters JJ. Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age. Physiol Genomics 2016;48:336-44. [PMID: 26884461 DOI: 10.1152/physiolgenomics.00129.2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
7 Drobny A, Ngo PA, Neurath MF, Zunke F, López-Posadas R. Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson's Disease. Front Med (Lausanne) 2021;8:655123. [PMID: 34368179 DOI: 10.3389/fmed.2021.655123] [Reference Citation Analysis]
8 Deleidi M, Gasser T. The role of inflammation in sporadic and familial Parkinson's disease. Cell Mol Life Sci 2013;70:4259-73. [PMID: 23665870 DOI: 10.1007/s00018-013-1352-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 13.8] [Reference Citation Analysis]
9 Brudek T. Inflammatory Bowel Diseases and Parkinson's Disease. J Parkinsons Dis 2019;9:S331-44. [PMID: 31609699 DOI: 10.3233/JPD-191729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 22.0] [Reference Citation Analysis]
10 Greene JG. Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson's disease. Antioxid Redox Signal 2014;21:649-67. [PMID: 24597973 DOI: 10.1089/ars.2014.5859] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
11 Ray B, Mahalakshmi AM, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C, Kannan A, Bolla SR, Chidambaram SB, Sakharkar MK. "Janus-Faced" α-Synuclein: Role in Parkinson's Disease. Front Cell Dev Biol 2021;9:673395. [PMID: 34124057 DOI: 10.3389/fcell.2021.673395] [Reference Citation Analysis]
12 Subramaniam SR, Federoff HJ. Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease. Front Aging Neurosci 2017;9:176. [PMID: 28642697 DOI: 10.3389/fnagi.2017.00176] [Cited by in Crossref: 127] [Cited by in F6Publishing: 116] [Article Influence: 31.8] [Reference Citation Analysis]
13 Mulak A, Bonaz B. Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 2015;21:10609-20. [PMID: 26457021 DOI: 10.3748/wjg.v21.i37.10609] [Cited by in CrossRef: 248] [Cited by in F6Publishing: 202] [Article Influence: 49.6] [Reference Citation Analysis]
14 Sanjari Moghaddam H, Valitabar Z, Ashraf-ganjouei A, Mojtahed Zadeh M, Ghazi Sherbaf F, Aarabi MH. Cerebrospinal Fluid C-Reactive Protein in Parkinson’s Disease: Associations with Motor and Non-motor Symptoms. Neuromol Med 2018;20:376-85. [DOI: 10.1007/s12017-018-8499-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Couch Y, Alvarez-Erviti L, Sibson NR, Wood MJ, Anthony DC. The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation. J Neuroinflammation 2011;8:166. [PMID: 22122884 DOI: 10.1186/1742-2094-8-166] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 9.9] [Reference Citation Analysis]
16 Alvarez-Arellano L, Maldonado-Bernal C. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 2014;5:400-404. [PMID: 25400983 DOI: 10.4291/wjgp.v5.i4.400] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 6.1] [Reference Citation Analysis]
17 Calderón-Garcidueñas L, D'Angiulli A, Kulesza RJ, Torres-Jardón R, Osnaya N, Romero L, Keefe S, Herritt L, Brooks DM, Avila-Ramirez J, Delgado-Chávez R, Medina-Cortina H, González-González LO. Air pollution is associated with brainstem auditory nuclei pathology and delayed brainstem auditory evoked potentials. Int J Dev Neurosci 2011;29:365-75. [PMID: 21458557 DOI: 10.1016/j.ijdevneu.2011.03.007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
18 Zhang Z, Hou L, Song JL, Song N, Sun YJ, Lin X, Wang XL, Zhang FZ, Ge YL. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models. Neuroscience 2014;257:20-30. [PMID: 24183966 DOI: 10.1016/j.neuroscience.2013.09.037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
19 Akıl E, Bulut A, Kaplan İ, Özdemir HH, Arslan D, Aluçlu MU. The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil/lymphocyte ratio in Parkinson's disease. Neurol Sci 2015;36:423-8. [PMID: 25288159 DOI: 10.1007/s10072-014-1976-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
20 Hernández-Romero MC, Delgado-Cortés MJ, Sarmiento M, de Pablos RM, Espinosa-Oliva AM, Argüelles S, Bández MJ, Villarán RF, Mauriño R, Santiago M, Venero JL, Herrera AJ, Cano J, Machado A. Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Neurotoxicology 2012;33:347-60. [PMID: 22330755 DOI: 10.1016/j.neuro.2012.01.018] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
21 Umemura A, Oeda T, Tomita S, Hayashi R, Kohsaka M, Park K, Sugiyama H, Sawada H. Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control study. PLoS One 2014;9:e94944. [PMID: 24887491 DOI: 10.1371/journal.pone.0094944] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
22 Manocha GD, Floden AM, Puig KL, Nagamoto-Combs K, Scherzer CR, Combs CK. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice. Mol Neurodegener 2017;12:17. [PMID: 28196514 DOI: 10.1186/s13024-017-0158-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
23 Tentillier N, Etzerodt A, Olesen MN, Rizalar FS, Jacobsen J, Bender D, Moestrup SK, Romero-Ramos M. Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model. J Neurosci 2016;36:9375-90. [PMID: 27605613 DOI: 10.1523/JNEUROSCI.1636-16.2016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 13.5] [Reference Citation Analysis]
24 Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Shirvan JC, Cedarbaum JM, Orr-Urtreger A, Regev K, Shenhar-Tsarfaty S, Mirelman A. Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers. J Parkinsons Dis 2021;11:1285-96. [PMID: 33998549 DOI: 10.3233/JPD-212624] [Reference Citation Analysis]
25 Murray CL, Skelly DT, Cunningham C. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6. J Neuroinflammation 2011;8:50. [PMID: 21586125 DOI: 10.1186/1742-2094-8-50] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
26 Xie X, Luo X, Liu N, Li X, Lou F, Zheng Y, Ren Y. Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system. J Neurochem 2017;141:222-35. [PMID: 28164283 DOI: 10.1111/jnc.13972] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
27 Terron A, Bal-Price A, Paini A, Monnet-Tschudi F, Bennekou SH, Leist M, Schildknecht S; EFSA WG EPI1 Members. An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition. Arch Toxicol 2018;92:41-82. [PMID: 29209747 DOI: 10.1007/s00204-017-2133-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
28 Tan BL, Norhaizan ME. Effect of High-Fat Diets on Oxidative Stress, Cellular Inflammatory Response and Cognitive Function. Nutrients 2019;11:E2579. [PMID: 31731503 DOI: 10.3390/nu11112579] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
29 Mulak A, Koszewicz M, Panek-Jeziorna M, Koziorowska-Gawron E, Budrewicz S. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease. Front Neurosci 2019;13:992. [PMID: 31611762 DOI: 10.3389/fnins.2019.00992] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
30 Gil-Martinez AL, Cuenca-Bermejo L, Gonzalez-Cuello AM, Sanchez-Rodrigo C, Parrado A, Vyas S, Fernandez-Villalba E, Herrero MT. Identification of differentially expressed genes profiles in a combined mouse model of Parkinsonism and colitis. Sci Rep 2020;10:13147. [PMID: 32753609 DOI: 10.1038/s41598-020-69695-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Stefano GB, Pilonis N, Ptacek R, Raboch J, Vnukova M, Kream RM. Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders. Cell Mol Neurobiol 2018;38:1197-206. [PMID: 29802603 DOI: 10.1007/s10571-018-0589-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
32 Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Transl Neurodegener 2015;4:19. [PMID: 26464797 DOI: 10.1186/s40035-015-0042-0] [Cited by in Crossref: 335] [Cited by in F6Publishing: 303] [Article Influence: 55.8] [Reference Citation Analysis]
33 Fritze D, Zhang W, Li JY, Chai B, Mulholland M. Thrombin mediates vagal apoptosis and dysfunction in inflammatory bowel disease. J Gastrointest Surg 2014;18:1495-506. [PMID: 24916589 DOI: 10.1007/s11605-014-2565-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
34 Shannon K, Vanden Berghe P. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell Tissue Res 2018;373:313-26. [PMID: 29936550 DOI: 10.1007/s00441-018-2856-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
35 Blaylock RL. Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity. Surg Neurol Int 2013;4:118. [PMID: 24083053 DOI: 10.4103/2152-7806.118349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
36 Hu Y, Yu SY, Zuo LJ, Piao YS, Cao CJ, Wang F, Chen ZJ, Du Y, Lian TH, Liu GF, Wang YJ, Chan P, Chen SD, Wang XM, Zhang W. Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD. PLoS One 2015;10:e0138997. [PMID: 26431210 DOI: 10.1371/journal.pone.0138997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
37 Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease. Mov Disord 2018;33:793-804. [PMID: 29572994 DOI: 10.1002/mds.27326] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 22.3] [Reference Citation Analysis]
38 Gharedaghi MH, Rahimian R, Dehpour AR, Yousefzadeh-fard Y, Mohammadi-farani A. Dinitrobenzene sulphonic acid-induced colitis impairs spatial recognition memory in mice: roles of N-methyl D-aspartate receptors and nitric oxide. Psychopharmacology 2015;232:3081-90. [DOI: 10.1007/s00213-015-3950-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Sandberg M, Patil J, D'Angelo B, Weber SG, Mallard C. NRF2-regulation in brain health and disease: implication of cerebral inflammation. Neuropharmacology 2014;79:298-306. [PMID: 24262633 DOI: 10.1016/j.neuropharm.2013.11.004] [Cited by in Crossref: 201] [Cited by in F6Publishing: 185] [Article Influence: 25.1] [Reference Citation Analysis]
40 Jackson A, Forsyth CB, Shaikh M, Voigt RM, Engen PA, Ramirez V, Keshavarzian A. Diet in Parkinson's Disease: Critical Role for the Microbiome. Front Neurol 2019;10:1245. [PMID: 31920905 DOI: 10.3389/fneur.2019.01245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
41 Dempsey E, Abautret-daly Á, Docherty NG, Medina C, Harkin A. Persistent central inflammation and region specific cellular activation accompany depression- and anxiety-like behaviours during the resolution phase of experimental colitis. Brain, Behavior, and Immunity 2019;80:616-32. [DOI: 10.1016/j.bbi.2019.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Zhu X, Han Y, Du J, Liu R, Jin K, Yi W. Microbiota-gut-brain axis and the central nervous system. Oncotarget 2017;8:53829-38. [PMID: 28881854 DOI: 10.18632/oncotarget.17754] [Cited by in Crossref: 109] [Cited by in F6Publishing: 84] [Article Influence: 27.3] [Reference Citation Analysis]
43 Wu ML, Yang XQ, Xue L, Duan W, Du JR. Age-related cognitive decline is associated with microbiota-gut-brain axis disorders and neuroinflammation in mice. Behav Brain Res 2021;402:113125. [PMID: 33422597 DOI: 10.1016/j.bbr.2021.113125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Castillo X, Castro-Obregón S, Gutiérrez-Becker B, Gutiérrez-Ospina G, Karalis N, Khalil AA, Lopez-Noguerola JS, Rodríguez LL, Martínez-Martínez E, Perez-Cruz C, Pérez-Velázquez J, Piña AL, Rubio K, García HPS, Syeda T, Vanoye-Carlo A, Villringer A, Winek K, Zille M. Re-thinking the Etiological Framework of Neurodegeneration. Front Neurosci 2019;13:728. [PMID: 31396030 DOI: 10.3389/fnins.2019.00728] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
45 Joers V, Vermilyea S, Dilley K, Emborg ME. Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculature. J Inflamm Res 2014;7:139-49. [PMID: 25258551 DOI: 10.2147/JIR.S67285] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
46 Jordan KR, Loman BR, Bailey MT, Pyter LM. Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities. Cancer 2018;124:3990-9. [PMID: 29975400 DOI: 10.1002/cncr.31584] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
47 Gil-Martínez AL, Estrada C, Cuenca L, Cano JA, Valiente M, Martínez-Cáceres CM, Fernández-Villalba E, Herrero MT. Local Gastrointestinal Injury Exacerbates Inflammation and Dopaminergic Cell Death in Parkinsonian Mice. Neurotox Res 2019;35:918-30. [PMID: 30796691 DOI: 10.1007/s12640-019-0010-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
48 Sohrabi M, Pecoraro HL, Combs CK. Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease. J Alzheimers Dis 2021;79:1235-55. [PMID: 33427741 DOI: 10.3233/JAD-201099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Camacho-Soto A, Gross A, Searles Nielsen S, Dey N, Racette BA. Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries. Parkinsonism Relat Disord 2018;50:23-8. [PMID: 29459115 DOI: 10.1016/j.parkreldis.2018.02.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
50 Huang Y, Halliday GM. Aspects of innate immunity and Parkinson's disease. Front Pharmacol 2012;3:33. [PMID: 22408621 DOI: 10.3389/fphar.2012.00033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
51 Abautret-Daly Á, Dempsey E, Parra-Blanco A, Medina C, Harkin A. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr 2018;30:275-96. [PMID: 28270247 DOI: 10.1017/neu.2017.3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
52 Chung JY, Park HR, Lee SJ, Lee SH, Kim JS, Jung YS, Hwang SH, Ha NC, Seol WG, Lee J, Park BJ. Elevated TRAF2/6 expression in Parkinson's disease is caused by the loss of Parkin E3 ligase activity. Lab Invest 2013;93:663-76. [PMID: 23608757 DOI: 10.1038/labinvest.2013.60] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
53 Machado A, Herrera AJ, Venero JL, Santiago M, de Pablos RM, Villarán RF, Espinosa-Oliva AM, Argüelles S, Sarmiento M, Delgado-Cortés MJ, Mauriño R, Cano J. Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons. ISRN Neurol 2011;2011:476158. [PMID: 22389821 DOI: 10.5402/2011/476158] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
54 Matt SM, Gaskill PJ. Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease. J Neuroimmune Pharmacol 2020;15:114-64. [PMID: 31077015 DOI: 10.1007/s11481-019-09851-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 21.0] [Reference Citation Analysis]
55 Walter U, Witt R, Wolters A, Wittstock M, Benecke R. Substantia nigra echogenicity in Parkinson's disease: relation to serum iron and C-reactive protein. J Neural Transm (Vienna) 2012;119:53-7. [PMID: 21626410 DOI: 10.1007/s00702-011-0664-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
56 Serres S, Bristow C, de Pablos RM, Merkler D, Soto MS, Sibson NR, Anthony DC. Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis. J Cereb Blood Flow Metab 2013;33:744-53. [PMID: 23423190 DOI: 10.1038/jcbfm.2013.12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
57 de Rus Jacquet A, Tambe MA, Rochet J. Dietary Phytochemicals in Neurodegenerative Disease. Nutrition in the Prevention and Treatment of Disease. Elsevier; 2017. pp. 361-91. [DOI: 10.1016/b978-0-12-802928-2.00018-7] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Cordaro M, Scuto M, Siracusa R, D'amico R, Filippo Peritore A, Gugliandolo E, Fusco R, Crupi R, Impellizzeri D, Pozzebon M, Alfonsi D, Mattei N, Marcolongo G, Evangelista M, Cuzzocrea S, Di Paola R. Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease. FASEB J 2020;34:4085-106. [PMID: 31950563 DOI: 10.1096/fj.201901584RR] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
59 Stefano GB, Kream RM. Mitochondrial DNA Heteroplasmy as an Informational Reservoir Dynamically Linked to Metabolic and Immunological Processes Associated with COVID-19 Neurological Disorders. Cell Mol Neurobiol 2021. [PMID: 34117968 DOI: 10.1007/s10571-021-01117-z] [Reference Citation Analysis]
60 Cunningham C, Skelly DT. Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium? J Neuroimmune Pharmacol. 2012;7:60-73. [PMID: 21932048 DOI: 10.1007/s11481-011-9312-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
61 Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia 2013;61:71-90. [PMID: 22674585 DOI: 10.1002/glia.22350] [Cited by in Crossref: 451] [Cited by in F6Publishing: 411] [Article Influence: 50.1] [Reference Citation Analysis]
62 Su X, Federoff HJ. Immune responses in Parkinson's disease: interplay between central and peripheral immune systems. Biomed Res Int 2014;2014:275178. [PMID: 24822191 DOI: 10.1155/2014/275178] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
63 Nuñez-Villena F, Becerra A, Echeverría C, Briceño N, Porras O, Armisén R, Varela D, Montorfano I, Sarmiento D, Simon F. Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid Redox Signal 2011;15:2425-38. [PMID: 21539414 DOI: 10.1089/ars.2010.3825] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
64 Fang X. Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis. Metab Brain Dis 2018;33:1031-43. [PMID: 29681010 DOI: 10.1007/s11011-018-0239-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
65 Hansen C, Li JY. Beyond α-synuclein transfer: pathology propagation in Parkinson’s disease. Trends Mol Med. 2012;18:248-255. [PMID: 22503115 DOI: 10.1016/j.molmed.2012.03.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
66 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 13.5] [Reference Citation Analysis]
67 Lyubashina OA, Sivachenko IB, Panteleev SS. Supraspinal Mechanisms of Intestinal Hypersensitivity. Cell Mol Neurobiol 2020. [PMID: 33030712 DOI: 10.1007/s10571-020-00967-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, Zhou X, Mo L, Chen L. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. [PMID: 32017453 DOI: 10.1002/brb3.1549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
69 Wang F, Sun L, Zhang XZ, Jia J, Liu Z, Huang XY, Yu SY, Zuo LJ, Cao CJ, Wang XM, Zhang W. Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease. Evid Based Complement Alternat Med 2015;2015:692795. [PMID: 26351515 DOI: 10.1155/2015/692795] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
70 Ghaisas S, Maher J, Kanthasamy A. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 2016;158:52-62. [PMID: 26627987 DOI: 10.1016/j.pharmthera.2015.11.012] [Cited by in Crossref: 208] [Cited by in F6Publishing: 171] [Article Influence: 34.7] [Reference Citation Analysis]
71 Olsen AL, Riise T, Scherzer CR. Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease. JAMA Neurol 2018;75:917-20. [PMID: 29710184 DOI: 10.1001/jamaneurol.2018.0345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Rolli-Derkinderen M, Leclair-Visonneau L, Bourreille A, Coron E, Neunlist M, Derkinderen P. Is Parkinson's disease a chronic low-grade inflammatory bowel disease? J Neurol 2020;267:2207-13. [PMID: 30989372 DOI: 10.1007/s00415-019-09321-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
73 Hanscom M, Loane DJ, Aubretch T, Leser J, Molesworth K, Hedgekar N, Ritzel RM, Abulwerdi G, Shea-Donohue T, Faden AI. Acute colitis during chronic experimental traumatic brain injury in mice induces dysautonomia and persistent extraintestinal, systemic, and CNS inflammation with exacerbated neurological deficits. J Neuroinflammation 2021;18:24. [PMID: 33461596 DOI: 10.1186/s12974-020-02067-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
74 Cunningham C. Systemic inflammation and delirium: important co-factors in the progression of dementia. Biochem Soc Trans 2011;39:945-53. [PMID: 21787328 DOI: 10.1042/BST0390945] [Cited by in Crossref: 80] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
75 Maneu V, Noailles A, Gómez-Vicente V, Carpena N, Cuenca N, Gil ML, Gozalbo D. Immunosuppression, peripheral inflammation and invasive infection from endogenous gut microbiota activate retinal microglia in mouse models. Microbiol Immunol 2016;60:617-25. [PMID: 27466067 DOI: 10.1111/1348-0421.12405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Zhang Y, Geng R, Tu Q. Gut microbial involvement in Alzheimer's disease pathogenesis. Aging (Albany NY) 2021;13. [PMID: 33971619 DOI: 10.18632/aging.202994] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Han Y, Zhao T, Cheng X, Zhao M, Gong SH, Zhao YQ, Wu HT, Fan M, Zhu LL. Cortical Inflammation is Increased in a DSS-Induced Colitis Mouse Model. Neurosci Bull 2018;34:1058-66. [PMID: 30225764 DOI: 10.1007/s12264-018-0288-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
78 Pradhan S, Andreasson K. Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease. Experimental Neurology 2013;241:148-55. [DOI: 10.1016/j.expneurol.2012.12.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
79 Tiwari RK, Moin A, Rizvi SMD, Shahid SMA, Bajpai P. Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug? Metab Brain Dis 2021;36:829-47. [PMID: 33704660 DOI: 10.1007/s11011-021-00696-6] [Reference Citation Analysis]
80 Machado A, Herrera AJ, Venero JL, Santiago M, De Pablos RM, Villarán RF, Espinosa-Oliva AM, Argüelles S, Sarmiento M, Delgado-Cortés MJ, Mauriño R, Cano J. Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence. Parkinsons Dis 2011;2011:393769. [PMID: 21603178 DOI: 10.4061/2011/393769] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
81 Umemura A, Oeda T, Yamamoto K, Tomita S, Kohsaka M, Park K, Sugiyama H, Sawada H. Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease. PLoS One 2015;10:e0136722. [PMID: 26308525 DOI: 10.1371/journal.pone.0136722] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
82 Giau VV, Wu SY, Jamerlan A, An SSA, Kim SY, Hulme J. Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease. Nutrients 2018;10:E1765. [PMID: 30441866 DOI: 10.3390/nu10111765] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 29.3] [Reference Citation Analysis]
83 Andersen HH, Johnsen KB, Moos T. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell Mol Life Sci 2014;71:1607-22. [PMID: 24218010 DOI: 10.1007/s00018-013-1509-8] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 11.4] [Reference Citation Analysis]
84 Jang JH, Yeom MJ, Ahn S, Oh JY, Ji S, Kim TH, Park HJ. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease. Brain Behav Immun 2020;89:641-55. [PMID: 32827699 DOI: 10.1016/j.bbi.2020.08.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
85 Wallings RL, Herrick MK, Tansey MG. LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's. Front Neurosci 2020;14:443. [PMID: 32508566 DOI: 10.3389/fnins.2020.00443] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 17.0] [Reference Citation Analysis]
86 Klingelhoefer L, Reichmann H. The Gut and Nonmotor Symptoms in Parkinson's Disease. Int Rev Neurobiol 2017;134:787-809. [PMID: 28805583 DOI: 10.1016/bs.irn.2017.05.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
87 Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, Bruley des Varannes S, Naveilhan P, Nguyen JM. Colonic inflammation in Parkinson's disease. Neurobiol Dis. 2013;50:42-48. [PMID: 23017648 DOI: 10.1016/j.nbd.2012.09.007] [Cited by in Crossref: 277] [Cited by in F6Publishing: 244] [Article Influence: 30.8] [Reference Citation Analysis]
88 Rokad D, Ghaisas S, Harischandra DS, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG. Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation. Brain Res Bull 2017;133:60-70. [PMID: 27993598 DOI: 10.1016/j.brainresbull.2016.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
89 Trivedi PP, Jena GB. Melatonin reduces ulcerative colitis-associated local and systemic damage in mice: investigation on possible mechanisms. Dig Dis Sci. 2013;58:3460-3474. [PMID: 23975342 DOI: 10.1007/s10620-013-2831-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
90 Blaylock RL. Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration. Surg Neurol Int 2017;8:65. [PMID: 28540131 DOI: 10.4103/sni.sni_441_16] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
91 Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, Zahoor H, Saeed D, Natteru PA, Iyer S, Zaheer A. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration. Front Cell Neurosci 2017;11:216. [PMID: 28790893 DOI: 10.3389/fncel.2017.00216] [Cited by in Crossref: 125] [Cited by in F6Publishing: 108] [Article Influence: 31.3] [Reference Citation Analysis]
92 Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, Jin L, Chen X. The progress of gut microbiome research related to brain disorders. J Neuroinflammation 2020;17:25. [PMID: 31952509 DOI: 10.1186/s12974-020-1705-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 50] [Article Influence: 71.0] [Reference Citation Analysis]
93 Banerjee A, Pradhan LK, Sahoo PK, Jena KK, Chauhan NR, Chauhan S, Das SK. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics. Arch Microbiol 2021;203:2895-910. [PMID: 33763767 DOI: 10.1007/s00203-021-02276-9] [Reference Citation Analysis]
94 Yan A, Song L, Zhang Y, Wang X, Liu Z. Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway. Front Aging Neurosci 2020;12:625166. [PMID: 33597857 DOI: 10.3389/fnagi.2020.625166] [Reference Citation Analysis]
95 Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, Rossi G, Eleuteri AM. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease. FEBS J 2021;288:2836-55. [PMID: 32969566 DOI: 10.1111/febs.15571] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
96 Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models. Mol Neurobiol 2018;55:7297-316. [PMID: 29404956 DOI: 10.1007/s12035-018-0937-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]
97 Trivedi PP, Jena GB. Ulcerative colitis-induced hepatic damage in mice: studies on inflammation, fibrosis, oxidative DNA damage and GST-P expression. Chem Biol Interact 2013;201:19-30. [PMID: 23261717 DOI: 10.1016/j.cbi.2012.12.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
98 Ferrari CC, Tarelli R. Parkinson's disease and systemic inflammation. Parkinsons Dis 2011;2011:436813. [PMID: 21403862 DOI: 10.4061/2011/436813] [Cited by in Crossref: 47] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
99 Liang CS, Bai YM, Hsu JW, Huang KL, Chu CS, Yeh TC, Tsai SJ, Chen TJ, Chen MH. The Risk of Alzheimer's Disease After Acute Appendicitis With or Without Appendectomy. J Am Med Dir Assoc 2021:S1525-8610(21)00571-5. [PMID: 34265267 DOI: 10.1016/j.jamda.2021.06.013] [Reference Citation Analysis]
100 de Rus Jacquet A, Subedi R, Ghimire SK, Rochet J. Nepalese traditional medicine and symptoms related to Parkinson׳s disease and other disorders: Patterns of the usage of plant resources along the Himalayan altitudinal range. Journal of Ethnopharmacology 2014;153:178-89. [DOI: 10.1016/j.jep.2014.02.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
101 Park S, Kim J, Chun J, Han K, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study. J Clin Med. 2019;8. [PMID: 31398905 DOI: 10.3390/jcm8081191] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
102 Hritcu L, Ciobica A, Stefan M, Mihasan M, Palamiuc L, Nabeshima T. Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease. Neuroscience Research 2011;71:35-43. [DOI: 10.1016/j.neures.2011.05.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
103 Espinosa-Oliva AM, de Pablos RM, Sarmiento M, Villarán RF, Carrillo-Jiménez A, Santiago M, Venero JL, Herrera AJ, Cano J, Machado A. Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures. Neurotoxicology 2014;41:89-101. [PMID: 24486959 DOI: 10.1016/j.neuro.2014.01.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
104 Bok E, Cho EJ, Chung ES, Shin WH, Jin BK. Interleukin-4 Contributes to Degeneration of Dopamine Neurons in the Lipopolysaccharide-treated Substantia Nigra in vivo. Exp Neurobiol 2018;27:309-19. [PMID: 30181693 DOI: 10.5607/en.2018.27.4.309] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
105 Saghazadeh A, Ferrari CC, Rezaei N. Deciphering variability in the role of interleukin-1β in Parkinson's disease. Rev Neurosci 2016;27:635-50. [PMID: 27166719 DOI: 10.1515/revneuro-2015-0059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
106 Cho J, Park YJ, Gonzales-Portillo B, Saft M, Cozene B, Sadanandan N, Borlongan CV. Gut dysbiosis in stroke and its implications on Alzheimer's disease-like cognitive dysfunction. CNS Neurosci Ther 2021;27:505-14. [PMID: 33464726 DOI: 10.1111/cns.13613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]